The major horse allergen Equ c 1 contains one immunodominant region of T cell epitopes

Background Despite the fact that most significant mammalian respiratory allergens are lipocalin proteins, information on the human T cell reactivity to these allergenic proteins is largely missing.

[1]  J. Partanen,et al.  The DR4–DQ8 haplotype and a specific T cell receptor Vβ T cell subset are associated with absence of allergy to Can f 1 , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[2]  R. O’Hehir,et al.  Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice , 1993, The Journal of experimental medicine.

[3]  E. Sercarz,et al.  How some T cells escape tolerance induction , 1989, Nature.

[4]  Dexiang Chen,et al.  Peptide induces CD4(+)CD25+ and IL-10+ T cells and protection in airway allergy models. , 2005, Vaccine.

[5]  Amos Bairoch,et al.  The PROSITE database, its status in 2002 , 2002, Nucleic Acids Res..

[6]  D. Wraith,et al.  Peptide-based therapeutic vaccines for allergic and autoimmune diseases , 2005, Nature Medicine.

[7]  Gajendra P. S. Raghava,et al.  ProPred: prediction of HLA-DR binding sites , 2001, Bioinform..

[8]  T. Platts-Mills,et al.  Different sensitization profile for asthma, rhinitis, and eczema among 7‐8‐year‐old children: Report from the Obstructive Lung Disease in Northern Sweden studies , 2003, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[9]  D R Flower,et al.  The lipocalin protein family: structural and sequence overview. , 2000, Biochimica et biophysica acta.

[10]  S. Atiş,et al.  Sensitization to horse hair, symptoms and lung function in grooms , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  C. Akdis,et al.  Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. , 1998, The Journal of allergy and clinical immunology.

[12]  R. Aalberse,et al.  The major dog allergens, Can f 1 and Can f 2, are salivary lipocalin proteins: cloning and immunological characterization of the recombinant forms , 1997, Immunology.

[13]  R. Simon,et al.  Expansion and Functional Relevance of High-Avidity Myelin-Specific CD4+ T Cells in Multiple Sclerosis , 2004, The Journal of Immunology.

[14]  R. Wood,et al.  Relation of CD4+CD25+ Regulatory T-Cell Suppression of Allergen-Driven T-Cell Activation to Atopic Status and Expression of Allergic Disease , 2005, Pediatrics.

[15]  D Norbäck,et al.  Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment. , 2005, Indoor air.

[16]  A. Rudin,et al.  Defective suppression of Th2 cytokines by CD4+CD25+ regulatory T cells in birch allergics during birch pollen season , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  P. Alzari,et al.  cDNA Cloning and Sequencing Reveal the Major Horse Allergen Equ c1 to Be a Glycoprotein Member of the Lipocalin Superfamily* , 1996, The Journal of Biological Chemistry.

[18]  J. Ceuppens,et al.  Allergen‐specific T cells from birch‐pollen‐allergic patients and healthy controls differ in T helper 2 cytokine and in interleukin‐10 production , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  F. Spertini,et al.  Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy. , 1997, The Journal of allergy and clinical immunology.

[20]  R. Garman,et al.  Definition of the human T-cell epitopes of Fel d 1, the major allergen of the domestic cat. , 1996, The Journal of allergy and clinical immunology.

[21]  Philippa Marrack,et al.  T cells down-modulate peptide-MHC complexes on APCs in vivo , 2002, Nature Immunology.

[22]  J. Pelkonen,et al.  Complementary DNA cloning of the predominant allergen of bovine dander: a new member in the lipocalin family. , 1996, The Journal of allergy and clinical immunology.

[23]  D R Flower,et al.  Lipocalins: unity in diversity. , 2000, Biochimica et biophysica acta.

[24]  Dominique Charron,et al.  HLA-DR Restricted Peptide Candidates for Bee Venom Immunotherapy , 2000, The Journal of Immunology.

[25]  H. Breiteneder,et al.  Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells. , 1998, The Journal of allergy and clinical immunology.

[26]  A. Närvänen,et al.  Immunomodulatory potential of heteroclitic analogs of the dominant T-cell epitope of lipocalin allergen Bos d 2 on specific T cells. , 2005, International immunology.

[27]  P. Cullinan,et al.  Determination of the T cell epitopes of the lipocalin allergen, Rat n 1 , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[28]  R. Simon,et al.  Redundancy in Antigen-Presenting Function of the HLA-DR and -DQ Molecules in the Multiple Sclerosis-Associated HLA-DR2 Haplotype1 , 2006, The Journal of Immunology.

[29]  G. Roberts,et al.  Horse allergy in children , 2000, BMJ : British Medical Journal.

[30]  B. Maillère,et al.  The immunodominant epitope of lipocalin allergen Bos d 2 is suboptimal for human T cells. , 2003, European journal of immunology.

[31]  Roberto Mallone,et al.  GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. , 2004, Diabetes.

[32]  T. Virtanen,et al.  Mammalian allergens. , 2004, Clinical allergy and immunology.

[33]  S. Auriola,et al.  Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  J. Drijfhout,et al.  HLA-DR binding analysis of peptides from islet antigens in IDDM. , 1998, Diabetes.

[35]  A. Rees,et al.  Properties of HLA class II molecules divergently associated with Goodpasture's disease. , 2000, International immunology.

[36]  A. Ménez,et al.  Complementarity and redundancy of the binding specificity of HLA‐DRB1, ‐DRB3, ‐DRB4 and ‐DRB5 molecules , 2001, European journal of immunology.

[37]  D. Wraith,et al.  Lowering the tone: mechanisms of immunodominance among epitopes with low affinity for MHC. , 1996, Immunology today.

[38]  J. Rouvinen,et al.  Molecular and crystal properties of Bos d 2, an allergenic protein of the lipocalin family. , 1998, Biochemical and biophysical research communications.

[39]  R. Mäntyjärvi,et al.  Allergy to lipocalins: a consequence of misguided T-cell recognition of self and nonself? , 1999, Immunology today.

[40]  E. Appella,et al.  Mechanisms influencing the immunodominance of T cell determinants , 1988, The Journal of experimental medicine.

[41]  D. Umetsu,et al.  The safety and efficacy of ALLERVAX CAT in cat allergic patients. , 1999, Clinical immunology.

[42]  H. Reijonen,et al.  Low‐avidity recognition by CD4+ T cells directed to self‐antigens , 2003, European journal of immunology.

[43]  M. Dallman,et al.  Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease , 2004, The Lancet.

[44]  Alain Sanson,et al.  HLA-DP4, the Most Frequent HLA II Molecule, Defines a New Supertype of Peptide-Binding Specificity1 , 2002, The Journal of Immunology.